John L. Villano, Md, Phd

This study looked at 76 people with advanced non-small cell lung cancer or head and neck squamous cell cancer who were already starting immunotherapy. Within two weeks of their first dose, they received a short course of radiation to one tumor site. The goal was to see if this co…

This study tested a combination of two immunotherapy drugs (durvalumab and tremelimumab) in 14 adults with solid tumors that had come back or stopped responding to treatment. To join, patients' tumors needed a high or moderate number of genetic mutations. The goal was to see if t…